Legal Claims
Hair Relaxer Lawsuit
If you used chemical hair relaxer products regularly and were later diagnosed with uterine or ovarian cancer, you may qualify for compensation.
Stay Informed
What's behind the hair relaxer claims?
Lawsuits allege that chemical hair relaxer and straightening products are linked to an increased risk of uterine, ovarian, and other cancers, and that manufacturers failed to warn users of the risk. The litigation has particularly focused on the impact on Black women, who have historically been the primary users of these products.
This is now one of the largest active mass-tort dockets in the country by number of plaintiffs.
Who this may affect
- Regular, long-term use of chemical hair relaxer or straightening products
- Later diagnosed with uterine, ovarian, or a related cancer
- Usage history and diagnosis can be documented
How this works
Here's what happens after you reach out:
01
Quick questions
A short set of free eligibility questions about your situation — takes about two minutes.
02
Free review
Our network reviews your answers against current qualifying criteria and reaches out if you may qualify.
03
No obligation
You decide whether to move forward. There's never a cost to check your eligibility.
Where things stand
As of July 2026, nearly 11,900 plaintiffs are part of the federal hair relaxer MDL before Judge Mary Rowland in the Northern District of Illinois. The litigation is currently in bellwether discovery and Daubert (expert-evidence) briefing — a phase that will help define eventual settlement values. Bellwether trials aren't expected before 2027, meaning any settlements are unlikely before 2027 or 2028.
Recent news
W
Atumio on 2026-07-23
A February 2026 case management order in the hair relaxer cancer MDL lays out a 90-day window for a deceased plaintiff's family or estate to formally take over her lawsuit. Here's how the process works.
Read more →
G
Atumio on 2026-07-23
A unanimous October 2025 Georgia Supreme Court ruling rejected a 'one and done' time-bar defense in a hair relaxer injury case, holding the state's 10-year statute of repose applies separately to each product sold.
Read more →
H
Atumio on 2026-07-23
On June 5, 2026, the federal judge overseeing the hair relaxer cancer MDL reappointed 38 plaintiffs' attorneys to leadership roles as the litigation, now covering thousands of women, moves toward bellwether trial selection.
Read more →
Atumio is a marketing/referral service, not a law firm, and this page is not legal advice.